Industry

DUBLIN–(BUSINESS WIRE)–The “Zolpidem (CAS 82626-48-0) Global Market Research Report 2022” report has been added to ResearchAndMarkets.com’s offering. This global report is a result of industry experts’ diligent work on researching the world market of Zolpidem. The report helps to build up a clear view of the market trends and development, identify major players in the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Tioclomarol (CAS 22619-35-8) Global Market Research Report 2022” report has been added to ResearchAndMarkets.com’s offering. This global report is a result of industry experts’ diligent work on researching the world market of Tioclomarol. The report helps to build up a clear view of the market trends and development, identify major players in the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Norfloxacin (CAS 70458-96-7) Global Market Research Report 2022” report has been added to ResearchAndMarkets.com’s offering. This global report is a result of industry experts’ diligent work on researching the world market of Norfloxacin. The report helps to build up a clear view of the market trends and development, identify major players in the … [Read more…]

Dutch hospital drives AI initiatives on a modern analytics and data lakehouse to support data-driven decision making and improve patient care AMSTERDAM–(BUSINESS WIRE)–Hewlett Packard Enterprise (NYSE: HPE) today announced that Catharina Hospital, the largest hospital in the Netherlands’ Eindhoven region, providing care for over 150,000 patients, has selected the HPE Ezmeral software portfolio to build … [Read more…]

LAUSANNE, Switzerland–(BUSINESS WIRE)–Gnubiotics Sciences, a biotech company pioneering the discovery and development of immunomodulatory glycopeptides, today announced that the Swiss Innovation Agency (Innosuisse) will support a research collaboration with the University Hospital Zürich to accelerate the development of Gnubiotics’ GLAAD technology in a range of solid tumors. The total project cost of CHF 1.4 million … [Read more…]

INGELHEIM, Germany & HAMBURG, Germany & MARCY-L’ÉTOILE, France–(BUSINESS WIRE)–Boehringer Ingelheim, a leading research-driven biopharmaceutical company, the life science company Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and bioMérieux, a world leader in in vitro diagnostics, announced today that they have formed a joint venture to create the next generation of antimicrobials … [Read more…]

BRANFORD, Conn. & NESS ZIONA, Israel–(BUSINESS WIRE)–BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announced today that it is voluntarily delisting its shares of common stock from trading on the Tel Aviv Stock Exchange (the “TASE”). Based upon … [Read more…]

– Mosunetuzumab could be the first CD20xCD3 T-cell engaging bispecific antibody approved by the FDA for the treatment of any type of non-Hodgkin’s lymphoma – – Application is based on results from the pivotal Phase I/II study showing mosunetuzumab induced high and durable complete response rates in people with follicular lymphoma who received two or … [Read more…]

Pfizer and Touchlight agree to patent license for Pfizer to utilise rapid, scalable, enzymatic doggybone DNA (dbDNA) in Pfizer’s clinical and commercial manufacture of its mRNA vaccines, therapeutics, and gene therapies Agreement includes upfront payment, potential development and commercial milestone payments, and royalties upon commercialization Access to dbDNA patent rights enables Pfizer’s rapid production of … [Read more…]

CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq: CERS) today announced the appointment of Hua Shan, MD, PhD, Professor of Pathology and Medical Director, Transfusion Medicine Service at Stanford Medical Center to its Board of Directors. “We are pleased to welcome Dr. Shan to Cerus’ Board of Directors,” said Daniel Swisher, Chair of the Board. “Dr. Shan is … [Read more…]